Wendy Deenik

Clear cell sarcoma (malignant melanoma) of soft parts

Wendy Deenik, Wolter J. Mooi, Emiel J. Rutgers et al. · Cancer · 1999 · 187 citations

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma

Sonja Zweegman, Bronno van der Holt, Ulf‐Henrik Mellqvist et al. · Blood · 2016 · 111 citations · Full text

<i>MYD88</i> mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis

Joost S.P. Vermaat, Sebastiaan Somers, Liesbeth C. de Wreede et al. · Haematologica · 2019 · 88 citations · Full text

Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch–Belgian Cooperative Trial for Haemato-Oncology (HOVON)

Noortje Thielen, Bronno van der Holt, Jan J. Cornelissen et al. · European Journal of Cancer · 2013 · 73 citations · Full text

Hematological Malignancy, Dutch–belgian Cooperative Trial, Oncology +10

Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib

Jeroen J. W. M. Janssen, Wendy Deenik, Karlijn G.M. Smolders et al. · Leukemia · 2011 · 34 citations

Hematological Malignancy, Oncology, Medicine +12